Loading clinical trials...
Loading clinical trials...
A 12-week Randomized, Double-blind, Placebo-controlled, Dose Ranging Phase 2 Study to Evaluate the Efficacy and Safety of RIST4721 in Subjects with Palmoplantar Pustulosis followed by an Open-label Ex...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Aristea Therapeutics, Inc.
NCT07013201 · Palmoplantar Pustulosis
NCT07530367 · Palmoplantar Pustulosis (PPP)
NCT05710185 · Palmoplantar Pustulosis
NCT04459507 · Palmoplantar Pustulosis
NCT03972280 · Hidradenitis Suppurativa, Palmoplantar Pustulosis
Total Skin & Beauty Dermatology Center, PC
Birmingham, Alabama
Dermatology Trial Associates
Bryant, Arkansas
Cosmetic Laser Dermatology
San Diego, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions